Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

Lignende værker

• Linking oncogenesis and immune system evasion in acquired resistance to EGFR-targeting antibodies: Lessons from a preclinical model
  af: Garrido, Greta, et al.
  Udgivet: (2013)
• EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab’s Clinical Effects
  af: Tania Crombet, et al.
  Udgivet: (2011-04-01)
• EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical Effects
  af: Perez, Rolando, et al.
  Udgivet: (2011)
• Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab')(2) Fragment in an Immunocompetent Mouse Model
  af: Rabasa Capote, Ailem, et al.
  Udgivet: (2012)
• Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft
  af: Hartimath, Siddesh V., et al.
  Udgivet: (2019)